These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group. Ohnishi K, Minami S, Ueda T, Nishimura M, Tsubaki K, Takemoto Y, Takeshita A, Sao H, Kageyama S, Ueda R, Ohno R. Int J Hematol; 2000 Aug; 72(2):229-36. PubMed ID: 11039674 [Abstract] [Full Text] [Related]
3. Prior treatment with alpha-interferon does not adversely affect the outcome of allogeneic BMT in chronic phase chronic myeloid leukemia. Zuffa E, Bandini G, Bonini A, Santucci MA, Martinelli G, Rosti G, Testoni N, Zaccaria A, Tura S. Haematologica; 1998 Mar; 83(3):231-6. PubMed ID: 9573677 [Abstract] [Full Text] [Related]
4. Chemotherapy and bone marrow transplantation in the treatment of chronic myelogenous leukemia. Kantarjian HM, Talpaz M. Semin Oncol; 1994 Dec; 21(6 Suppl 14):8-13. PubMed ID: 7992099 [Abstract] [Full Text] [Related]
5. [Indications, technique and risks in bone marrow transplantation in adulthood]. Heyll A, Söhngen D, Minning H, Meckenstock G, Aul C, Schneider W. Praxis (Bern 1994); 1996 Mar 19; 85(12):378-86. PubMed ID: 8643901 [Abstract] [Full Text] [Related]
6. Interferon alpha for chronic myeloid leukemia relapsing after allogeneic bone marrow transplantation. Steegmann JL, Casado LF, Tomás JF, Sanz-Rodríguez C, Granados E, de la Cámara R, Alegre A, Vázquez L, Ferro MT, Figuera A, Arranz R, Fernández-Rañada JM. Bone Marrow Transplant; 1999 Mar 19; 23(5):483-8. PubMed ID: 10100563 [Abstract] [Full Text] [Related]
7. The evolving role of bone marrow transplantation in the treatment of chronic myelogenous leukemia. Delage R, Ritz J, Anderson KC. Hematol Oncol Clin North Am; 1990 Apr 19; 4(2):369-88. PubMed ID: 2182597 [Abstract] [Full Text] [Related]
8. Absence of influence of prior treatment with interferon on the outcome of allogeneic bone marrow transplantation for chronic myeloid leukemia. Tomás JF, López-Lorenzo JL, Requena MJ, Aguilar R, Steegmann JL, Cámara R, Alegre A, Arranz R, Figuera A, Fernández-Rañada JM. Bone Marrow Transplant; 1998 Jul 19; 22(1):47-51. PubMed ID: 9678795 [Abstract] [Full Text] [Related]
9. Autologous bone marrow transplantation for leukemia. Stuart RK. Semin Oncol; 1993 Oct 19; 20(5 Suppl 6):40-54. PubMed ID: 8211215 [Abstract] [Full Text] [Related]
10. [Chronic myeloid leukemia]. Hehlmann R. Ther Umsch; 1996 Feb 19; 53(2):82-7. PubMed ID: 8629268 [Abstract] [Full Text] [Related]
11. Role of pretransplant interferon-alpha(IFN) treatment in the outcome of stem cell transplantation (SCT) from related donors in chronic myelogenous leukemia (CML): results from three Turkish transplant centers. Beksac M, Celebi H, Sargín D, Yalcin A, Topcuoglu P, Kalayoglu-Besisik S, Beyan C, Arslan O, Ozcan M, Gurman G, Ilhan O, Akan H. Bone Marrow Transplant; 2003 May 19; 31(10):897-904. PubMed ID: 12748666 [Abstract] [Full Text] [Related]
12. Chronic myelogenous leukemia and acute promyelocytic leukemia: new bone marrow transplantation options. Viele CS. Oncol Nurs Forum; 1996 Apr 19; 23(3):488-93. PubMed ID: 8801509 [Abstract] [Full Text] [Related]
13. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells. Carlo-Stella C, Regazzi E, Andrizzi C, Savoldo B, Garau D, Montefusco E, Vignetti M, Mandelli F, Rizzoli V, Meloni G. Haematologica; 1997 Apr 19; 82(3):291-6. PubMed ID: 9234574 [Abstract] [Full Text] [Related]
14. Chronic myelogenous leukemia: state of the art. Polli EE, Pozzoli E, Annaloro C. Ann Ital Med Int; 1991 Apr 19; 6(4 Pt 2):491-7. PubMed ID: 1840816 [Abstract] [Full Text] [Related]
15. Prolonged chronic phase in chronic myelogenous leukemia after homoharringtonine therapy. Li YF, Deng ZK, Xuan HB, Zhu JB, Ding BH, Liu XN, Chen BA. Chin Med J (Engl); 2009 Jun 20; 122(12):1413-7. PubMed ID: 19567163 [Abstract] [Full Text] [Related]
16. [Autologous hemopoietic stem cell transplantation in treatment of chronic myelogenous leukemia]. Sacha T, Hawrylecka D, Skotnicki AB. Przegl Lek; 1999 Jun 20; 56 Suppl 1():62-6. PubMed ID: 10494185 [Abstract] [Full Text] [Related]
17. Fate of chronic myeloid leukemia patients treated with allogeneic bone marrow transplantation or chemotherapy and/or interferon at a single center: long-term results. Gaziev D, Galimberti M, Polchi P, Angelucci E, Giardini C, Baronciani D, Andreani M, Persini B, Erer B, Sodani P, Manna M, Nicolini G, Visani G, Lucarelli G, AIEOP. Bone Marrow Transplant; 2002 Jan 20; 29(1):1-8. PubMed ID: 11840137 [Abstract] [Full Text] [Related]
18. [Autologous bone marrow transplantation in chronic myelogenous leukemia]. Ogura H, Shirafuji N. Rinsho Ketsueki; 1991 Apr 20; 32(4):386-90. PubMed ID: 2067083 [Abstract] [Full Text] [Related]
19. Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease. Posthuma EF, Marijt EW, Barge RM, van Soest RA, Baas IO, Starrenburg CW, van Zelderen-Bhola SL, Fibbe WE, Smit WM, Willemze R, Falkenburg JH. Biol Blood Marrow Transplant; 2004 Mar 20; 10(3):204-12. PubMed ID: 14993886 [Abstract] [Full Text] [Related]
20. Early allogeneic stem cell transplantation for chronic myelogenous leukemia in the imatinib era: a preliminary assessment. Simon W, Segel GB, Lichtman MA. Blood Cells Mol Dis; 2006 Mar 20; 37(2):116-24; discussion 125-7. PubMed ID: 16904348 [Abstract] [Full Text] [Related] Page: [Next] [New Search]